The Impact of Aging on MS: Comorbidities, Polypharmacy and Disease Modifying Treatments
Melinda Magyari and Thomas Berger discuss the effects of aging on Multiple Sclerosis, including immunosenescence, comorbidities, and challenges with Disease Modifying Treatments (DMTs) in patients over 55. The episode also offers lifestyle advice for improving health outcomes.